ArticleJournal of virology2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
Jingyu Xiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleJournal of virology2022
Jingyu Xiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.